Andrew joined the MHRA in January 2003 as a GLP inspector. In 2004 Andrew was appointed Operations Manager for the Good Laboratory Practise and Good Distribution Practise Groups, taking responsibility for the management of a team of ten inspectors. In May 2006 Andrew took on the role of Heads of the United Kingdom Good Laboratory Monitoring Authority. In this capacity he holds the chair of the OECD GLP Working Group and is a member of the EC GLP Working Group.
Andrew has contributed to a number of national and international guidance documents including the first comprehensive European guidance for laboratories that perform the analysis of samples collected as part of clinical trials. In 2014 Andrew was appointed to the role of Unit Manager Inspectorate Operations with responsibility for the GLP, GCP and GDP inspection teams.
Prior to joining the MHRA, Andrew worked in academia for a number of years performing research on the underlying causes of cardiovascular disease before moving into the pharmaceutical sector where he was involved in pre-clinical drug development.